0001493152-23-036522.txt : 20231006 0001493152-23-036522.hdr.sgml : 20231006 20231006163335 ACCESSION NUMBER: 0001493152-23-036522 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231004 FILED AS OF DATE: 20231006 DATE AS OF CHANGE: 20231006 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GANDOLFO JOHN P CENTRAL INDEX KEY: 0001200155 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32188 FILM NUMBER: 231314599 MAIL ADDRESS: STREET 1: 62 TERRACE ROAD CITY: WAYNE STATE: NJ ZIP: 07470 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ORAGENICS INC CENTRAL INDEX KEY: 0001174940 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 593410522 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4902 EISENHOWER BLVD STREET 2: SUITE 125 CITY: TAMPA STATE: FL ZIP: 33634 BUSINESS PHONE: 8132867900 MAIL ADDRESS: STREET 1: 4902 EISENHOWER BLVD STREET 2: SUITE 125 CITY: TAMPA STATE: FL ZIP: 33634 4 1 ownership.xml X0508 4 2023-10-04 0 0001174940 ORAGENICS INC OGEN 0001200155 GANDOLFO JOHN P 4902 EISENHOWER BOULEVARD TAMPA FL 33634 1 0 0 0 0 Non-Employee Director Option (Right to Buy) 2.94 2023-10-04 4 A 0 5102 0 A 2033-10-04 Common Stock 5102 5102 D Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately. /s/ Julio C. Esquivel, as Attorney-in-Fact for John Gandolfo 2023-10-06